BuzzSparks.org

Avidia


biopharmaceutical company

Avidia, Inc., a biopharmaceutical company, engages in discovering and developing therapeutic proteins. The company offers Avimer therapeutic proteins, which are used to address various therapeutic areas, including autoimmunity, inflammation,...

Founded in 2003
Homepage:
Total money raised: $72.3M

HQ

94043 2450 Bayshore Parkway
2nd Floor

Mountain View
USA CA

Phone: 650-404-2000

Updated on Jul 2, 2010
Avidia at CrunchBase
Past
Leighton Read CEO
Mark Juliano Founder
Geoffrey Duyk Board Member
Ralph E. Christoffersen
Paul May Director of Financ

October, 2008

Avidia was acquired by Amgen
for $380M

Amgen to buy inflammation drug co. Avidia for up to $380M    deals.venturebeat.com

May, 2006

Avidia raised $43.8M in a Series C round from Skyline Ventures, HealthCare Ventures, Alloy Ventures, Amgen, MedImmune Ventures, Morgenthaler Ventures, and Texas Pacific Group

AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS    freshnews.com

May, 2005

Avidia raised $28.5M in a Series B round from MedImmune Ventures and Amgen

AVIDIA ADVANCING LEAD PRODUCT THROUGH $28.5M SERIES B ROUND.    thefreelibrary.com

2003

Avidia was founded in 2003